Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Roth

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
ACS Synthetic Biology|November 21, 2018
Phosphate Lock Residues of Acidothermus cellulolyticus Cas9 Are Critical to Its Substrate SpecificityTravis H Hand, Anuska Das, Mitchell O Roth, et al.
The CRISPR Journal|April 20, 2021
Catalytically Enhanced Cas9 through Directed Protein EvolutionTravis H Hand, Mitchell O Roth, Chardasia L Smith, et al.
Annales De Cardiologie Et D'Angeiologie|October 22, 2008
[Non ST elevation acute coronary syndromes and normal coronary angiography: is it truly good news?]J-P Monassier, L Jacquemin, O Roth, et al.
Peerj|December 21, 2017
How many species of mammals are there in Brazil? New records of rare rodents (Rodentia: Cricetidae: Sigmodontinae) from Amazonia raise the current known diversityAlexandre R Percequillo, Jeronymo Dalapicolla, Edson F Abreu-Júnior, et al.
Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Nature|April 15, 2026
Molecular basis for methylation-sensitive editing by Cas9Mitchell O Roth, Yuerong Shu, Yu Zhao, et al.
European Heart Journal|March 4, 2014
No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admissionF Roubille, N Mewton, M Elbaz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
ACS Synthetic Biology|November 21, 2018
Phosphate Lock Residues of Acidothermus cellulolyticus Cas9 Are Critical to Its Substrate SpecificityTravis H Hand, Anuska Das, Mitchell O Roth, et al.
The CRISPR Journal|April 20, 2021
Catalytically Enhanced Cas9 through Directed Protein EvolutionTravis H Hand, Mitchell O Roth, Chardasia L Smith, et al.
Annales De Cardiologie Et D'Angeiologie|October 22, 2008
[Non ST elevation acute coronary syndromes and normal coronary angiography: is it truly good news?]J-P Monassier, L Jacquemin, O Roth, et al.
Peerj|December 21, 2017
How many species of mammals are there in Brazil? New records of rare rodents (Rodentia: Cricetidae: Sigmodontinae) from Amazonia raise the current known diversityAlexandre R Percequillo, Jeronymo Dalapicolla, Edson F Abreu-Júnior, et al.
Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Nature|April 15, 2026
Molecular basis for methylation-sensitive editing by Cas9Mitchell O Roth, Yuerong Shu, Yu Zhao, et al.
European Heart Journal|March 4, 2014
No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admissionF Roubille, N Mewton, M Elbaz, et al.
Pageof 3